Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Randomized phase II trial of lenalidomide with low-dose dexamethasone versus lenalidomide alone as maintenance therapy in multiple myeloma
2010-021857-38Phase 2Completed
- Sponsor
- Karolinska University Hospital
- Start
- Dec 2010
- Modality
- Small Molecules
- Countries
- 1
01
Overview
Phase 2, randomised trial of lenalidomide in multiple myeloma (MM) (2 arms), sponsored by Karolinska University Hospital. Primary endpoint: Time to progression (TTP). Started Dec 2010; status: completed.
02
Drugs
lenalidomide
03
Conditions
multiple myeloma (MM)
Beyond the preview
Go deeper on 2010-021857-38.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on 2010-021857-38.